细胞淋巴瘤-话题@MedSci

#细胞淋巴瘤#

385篇内容 | 5352人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1702556, encodeId=f5b01e02556a8, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2019.V3）, objectType=article, longId=161603, objectId=de55161603d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de55161603d4, replyNumber=0, likeNumber=23, createdTime=2019-09-26, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de55161603d4, moduleTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2019.V3）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=de55161603d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702560, encodeId=fa401e0256089, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2019.V4）, objectType=article, longId=163724, objectId=7dec163e2405, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7dec163e2405, replyNumber=0, likeNumber=26, createdTime=2020-02-10, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7dec163e2405, moduleTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2019.V4）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7dec163e2405)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702559, encodeId=acfe1e02559a7, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：B细胞淋巴瘤（2019.V2）, objectType=article, longId=163343, objectId=63e8163343c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63e8163343c3, replyNumber=0, likeNumber=26, createdTime=2019-11-09, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63e8163343c3, moduleTitle=NCCN临床实践指南：B细胞淋巴瘤（2019.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63e8163343c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702566, encodeId=ed0d1e02566a9, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：ALK阴性的间变性大细胞淋巴瘤的复发性MSCE116K突变, objectType=article, longId=166328, objectId=43451663282e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43451663282e, replyNumber=0, likeNumber=77, createdTime=2019-11-28, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43451663282e, moduleTitle=Blood：ALK阴性的间变性大细胞淋巴瘤的复发性MSCE116K突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43451663282e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702531, encodeId=f2791e0253172, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=腰椎管狭窄症合并左骶髂关节弥漫性大B细胞淋巴瘤1例, objectType=article, longId=154662, objectId=d1d31546622a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1d31546622a, replyNumber=0, likeNumber=63, createdTime=2019-07-14, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1d31546622a, moduleTitle=腰椎管狭窄症合并左骶髂关节弥漫性大B细胞淋巴瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1d31546622a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702508, encodeId=88371e025086c, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：T细胞淋巴瘤（2018.V5）, objectType=article, longId=146746, objectId=313c146e46f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=313c146e46f5, replyNumber=0, likeNumber=27, createdTime=2019-06-16, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=313c146e46f5, moduleTitle=NCCN临床实践指南：T细胞淋巴瘤（2018.V5）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=313c146e46f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702557, encodeId=3db71e0255759, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=2018 JSH实践指南：血液恶性肿瘤—成人T细胞白血病-淋巴瘤-9.结节外NK／T细胞淋巴瘤（鼻型）, objectType=article, longId=162428, objectId=0d4316242859, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d4316242859, replyNumber=0, likeNumber=15, createdTime=2019-09-24, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d4316242859, moduleTitle=2018 JSH实践指南：血液恶性肿瘤—成人T细胞白血病-淋巴瘤-9.结节外NK／T细胞淋巴瘤（鼻型）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d4316242859)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702539, encodeId=b1331e02539af, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=蔡清清教授：老年弥漫性大B细胞淋巴瘤治疗窘境仍待破解, objectType=article, longId=155982, objectId=6be11559825a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6be11559825a, replyNumber=0, likeNumber=60, createdTime=2019-11-08, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6be11559825a, moduleTitle=蔡清清教授：老年弥漫性大B细胞淋巴瘤治疗窘境仍待破解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6be11559825a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702514, encodeId=97591e02514b2, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=西达本胺治疗外周T细胞淋巴瘤中国专家共识（2018年版）, objectType=article, longId=148167, objectId=f37114816eaa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f37114816eaa, replyNumber=0, likeNumber=28, createdTime=2018-10-20, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f37114816eaa, moduleTitle=西达本胺治疗外周T细胞淋巴瘤中国专家共识（2018年版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f37114816eaa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702517, encodeId=5de31e0251774, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：在弥漫性大B细胞淋巴瘤中，B细胞受体介导的NFATc1激活可诱导IL-10/STAT3/PD-L1信号, objectType=article, longId=148786, objectId=bee6148e86b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bee6148e86b0, replyNumber=0, likeNumber=71, createdTime=2018-09-30, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bee6148e86b0, moduleTitle=Blood：在弥漫性大B细胞淋巴瘤中，B细胞受体介导的NFATc1激活可诱导IL-10/STAT3/PD-L1信号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bee6148e86b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702510, encodeId=e2fa1e0251012, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=专家“亿”周谈——六年磨一剑：从2012到2018年，BSH套细胞淋巴瘤指南有哪些变化, objectType=article, longId=147237, objectId=dd3114e23757, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd3114e23757, replyNumber=0, likeNumber=18, createdTime=2019-04-15, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd3114e23757, moduleTitle=专家“亿”周谈——六年磨一剑：从2012到2018年，BSH套细胞淋巴瘤指南有哪些变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd3114e23757)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702548, encodeId=a4fb1e0254854, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=百济神州宣布美国食品药品监督管理局（FDA）授予Zanubrutinib突破性疗法认定用于治疗套细胞淋巴瘤患者, objectType=article, longId=158141, objectId=4f381581410d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f381581410d, replyNumber=0, likeNumber=63, createdTime=2019-03-19, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f381581410d, moduleTitle=百济神州宣布美国食品药品监督管理局（FDA）授予Zanubrutinib突破性疗法认定用于治疗套细胞淋巴瘤患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f381581410d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702524, encodeId=db981e025249c, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=ARCH PATHOL LAB MED：幔细胞淋巴瘤的免疫表型变异及其对临床行为和预后的影响, objectType=article, longId=152348, objectId=9917152348a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9917152348a1, replyNumber=0, likeNumber=48, createdTime=2019-08-25, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9917152348a1, moduleTitle=ARCH PATHOL LAB MED：幔细胞淋巴瘤的免疫表型变异及其对临床行为和预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9917152348a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702526, encodeId=93bb1e0252651, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：囊胚和多形性套细胞淋巴瘤的诊断和治疗！, objectType=article, longId=152692, objectId=e81e1526923d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e81e1526923d, replyNumber=0, likeNumber=67, createdTime=2018-12-05, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e81e1526923d, moduleTitle=Blood：囊胚和多形性套细胞淋巴瘤的诊断和治疗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e81e1526923d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702519, encodeId=db8a1e025195c, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Portola口服Syk/JAK抑制剂Cerdlatinib治疗外周T细胞淋巴瘤获得FDA孤儿药物指定, objectType=article, longId=149700, objectId=ed23149e009d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed23149e009d, replyNumber=0, likeNumber=70, createdTime=2019-06-02, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed23149e009d, moduleTitle=Portola口服Syk/JAK抑制剂Cerdlatinib治疗外周T细胞淋巴瘤获得FDA孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed23149e009d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702498, encodeId=1e7b1e02498c2, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Lancet Haematol：R-GemOx一线治疗弥漫性大B细胞淋巴瘤老年患者怎么样？, objectType=article, longId=144538, objectId=cc1d14453882, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc1d14453882, replyNumber=0, likeNumber=75, createdTime=2018-12-28, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc1d14453882, moduleTitle=Lancet Haematol：R-GemOx一线治疗弥漫性大B细胞淋巴瘤老年患者怎么样？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc1d14453882)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702532, encodeId=59e91e0253298, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：MCL1抑制为T细胞淋巴瘤患者带来新的治疗希望！, objectType=article, longId=155021, objectId=06ab15502189, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06ab15502189, replyNumber=0, likeNumber=56, createdTime=2019-05-28, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06ab15502189, moduleTitle=Blood：MCL1抑制为T细胞淋巴瘤患者带来新的治疗希望！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06ab15502189)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702502, encodeId=2f301e02502b5, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：在自然杀伤T细胞淋巴瘤中，STAT3信号通路激活可上调PD-L1的表达！, objectType=article, longId=145638, objectId=7bf3145638e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bf3145638e4, replyNumber=0, likeNumber=79, createdTime=2019-02-25, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bf3145638e4, moduleTitle=Blood：在自然杀伤T细胞淋巴瘤中，STAT3信号通路激活可上调PD-L1的表达！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bf3145638e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702527, encodeId=49191e02527ed, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Am J Hematol：套细胞淋巴瘤：利妥昔单抗维持治疗效果喜人, objectType=article, longId=153070, objectId=9c1a1530e044, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c1a1530e044, replyNumber=0, likeNumber=76, createdTime=2019-06-26, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c1a1530e044, moduleTitle=Am J Hematol：套细胞淋巴瘤：利妥昔单抗维持治疗效果喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c1a1530e044)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702549, encodeId=e2861e0254901, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Lancet Haematol：MYC基因重排侵袭性B细胞淋巴瘤可考虑剂量调整的EPOCH-R方案, objectType=article, longId=158333, objectId=632d1583337f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=632d1583337f, replyNumber=0, likeNumber=63, createdTime=2019-07-13, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=632d1583337f, moduleTitle=Lancet Haematol：MYC基因重排侵袭性B细胞淋巴瘤可考虑剂量调整的EPOCH-R方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=632d1583337f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞淋巴瘤

2020-05-29

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2019.V3）

2019-09-26

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2019.V4）

2020-02-10

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：B细胞淋巴瘤（2019.V2）

2019-11-09

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：ALK阴性的间变性大细胞淋巴瘤的复发性MSCE116K突变

2019-11-28

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

腰椎管狭窄症合并左骶髂关节弥漫性大B细胞淋巴瘤1例

2019-07-14

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：T细胞淋巴瘤（2018.V5）

2019-06-16

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

2018 JSH实践指南：血液恶性肿瘤—成人T细胞白血病-淋巴瘤-9.结节外NK／T细胞淋巴瘤（鼻型）

2019-09-24

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

蔡清清教授：老年弥漫性大B细胞淋巴瘤治疗窘境仍待破解

2019-11-08

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

西达本胺治疗外周T细胞淋巴瘤中国专家共识（2018年版）

2018-10-20

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：在弥漫性大B细胞淋巴瘤中，B细胞受体介导的NFATc1激活可诱导IL-10/STAT3/PD-L1信号

2018-09-30

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

专家“亿”周谈——六年磨一剑：从2012到2018年，BSH套细胞淋巴瘤指南有哪些变化

2019-04-15

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

百济神州宣布美国食品药品监督管理局（FDA）授予Zanubrutinib突破性疗法认定用于治疗套细胞淋巴瘤患者

2019-03-19

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

ARCH PATHOL LAB MED：幔细胞淋巴瘤的免疫表型变异及其对临床行为和预后的影响

2019-08-25

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：囊胚和多形性套细胞淋巴瘤的诊断和治疗！

2018-12-05

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Portola口服Syk/JAK抑制剂Cerdlatinib治疗外周T细胞淋巴瘤获得FDA孤儿药物指定

2019-06-02

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Lancet Haematol：R-GemOx一线治疗弥漫性大B细胞淋巴瘤老年患者怎么样？

2018-12-28

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：MCL1抑制为T细胞淋巴瘤患者带来新的治疗希望！

2019-05-28

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：在自然杀伤T细胞淋巴瘤中，STAT3信号通路激活可上调PD-L1的表达！

2019-02-25

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Am J Hematol：套细胞淋巴瘤：利妥昔单抗维持治疗效果喜人

2019-06-26

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Lancet Haematol：MYC基因重排侵袭性B细胞淋巴瘤可考虑剂量调整的EPOCH-R方案

2019-07-13

科室
- - 订阅+
  - 更多科室
工具
服务